Social Determinants and a Diabetes Prevention Program Tailored for African Americans

NCT ID: NCT05301413

Last Updated: 2025-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

360 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-20

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

African Americans (AAs) have rates of diabetes mellitus (DM) twice that of Whites and are disproportionately affected by leading risk factors for DM - obesity and low-income. A critical strategy in the battle against DM is the Diabetes Prevention Program (DPP), an evidence-based intervention that significantly delays or prevents Type 2 diabetes through the promotion of diet change, exercise and modest weight loss. However, weight loss from the DPP among AAs is about half that of White participants, and suboptimal AA attendance is a critical contributor. The investigators propose to conduct a study that will address social determinants (SD) that challenge DPP attendance with underserved African Americans from a safety net hospital. The investigators will examine DPP attendance and weight loss with participants randomized to 3 groups: standard DPP, a culturally-tailored DPP to address acceptability, and a culturally-tailored DPP enhanced to address socioeconomic-related barriers to DPP participation. This novel study is the first to tailor the DPP to address SD cultural and socioeconomic barriers that limit DPP attendance and reduce its effectiveness on outcomes. The proposed multidimensional, SD tailored DPP has great potential to be a feasible and scalable model to reduce DM risks among urban, African Americans and ultimately reduce DM disparities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

African Americans (AAs) are disproportionately burdened by diabetes mellitus (DM) with rates twice as high as Whites (13% vs 7.5%), and increased rates of DM-related complications and comorbidities (e.g. amputations, cardiovascular disease). A key pre-DM risk factor is overweight/obesity. Nearly 70% of AAs are overweight or obese, with higher rates among AAs with low-income. A critical component of national efforts to reduce growing obesity rates and prevent DM is the Diabetes Prevention Program (DPP), a lifestyle intervention proven to reduce or delay DM onset with diet change, exercise, and modest weight loss (5-7%) in a rigorously evaluated national trial. A group-based version of the DPP has been widely disseminated and numerous community-based trials support its efficacy. In spite of these successes, there are significant health disparities in DPP attendance and outcomes and considerable room exists for improving success rates among AAs, a population that tends to experience half the amount of DPP weight loss compared to Whites. The investigators aim to build on our promising pilot studies by tailoring the DPP via a social determinants (SD) of health lens to achieve optimal DPP attendance and clinically meaningful weight loss with pre-DM AAs. This includes tailoring on cultural and socioeconomic SD mechanisms that are associated with improving health outcomes and align with predisposing needs among AAs who are primarily of low-income and live in low-resource AA communities.

The investigators propose a randomized controlled trial of 360 pre-DM AA patients from a safety net hospital (SNH) to test a standard DPP (S-DPP) against a culturally tailored DPP (TC-DPP; e.g., tailoring of language, foods, values, religiosity, norms, values) alone and a culturally tailored DPP enhanced to address access and support related economic barriers (TCE-DPP; hybrid group/online/text DPP; community health worker support to improve access to DPP classes, healthy food, exercise, and other community and health resources; and class promotions) over 12 months. The investigators will: 1) examine effects of TC-DPP and TCE-DDP on percent weight loss and attendance (primary outcomes) and on secondary outcomes (physical activity, completion of physician follow-up visit, hbA1c, and blood pressure) at 6 and 12 months with SNH AAs, 2) evaluate potential mediators/ moderators related to weight loss and attendance among AA SNH patients at 6 and 12 months to determine modifiable facilitators and barriers, and 3) conduct a process evaluation to examine TCE-DPP acceptability, feasibility, and fidelity, and relationships between delivery dose, exposure, costs, and outcomes to identify and improve essential intervention components. Our multidimensional DPP interventions are guided by our past pilots, and based on components that, all together, were used to help drive clinically important outcomes in the original DPP trial - and are certainly needed to achieve similar outcomes with AA primarily of low-income. To our knowledge this is the first study to test multidimensional tailoring via an SD lens to truly impact DPP attendance and outcomes, and has potential to be a feasible, scalable model to reduce DM disparities among at-risk AA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PreDiabetes Overweight and Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard

Standard Diabetes Prevention Program (DPP)

Group Type ACTIVE_COMPARATOR

Diabetes Prevention Program

Intervention Type BEHAVIORAL

This is the CDC TD2 evidence-based Diabetes Prevention Program

Culturally Tailored DPP

DPP culturally tailored for African Americans

Group Type EXPERIMENTAL

Culturally Tailored Diabetes Prevention Program

Intervention Type BEHAVIORAL

This intervention includes a culturally tailored DPP curriculum, class procedures, and handouts

Diabetes Prevention Program

Intervention Type BEHAVIORAL

This is the CDC TD2 evidence-based Diabetes Prevention Program

Culturally Tailored DPP Enhanced with Socioeconomic Supports

Culturally tailored DPP plus promotions for class attendance, hybrid attendance (in-person and virtual), and linkage to care services provided by a community health worker

Group Type EXPERIMENTAL

Culturally Tailored Diabetes Prevention Program

Intervention Type BEHAVIORAL

This intervention includes a culturally tailored DPP curriculum, class procedures, and handouts

Culturally Tailored DPP Enhanced with Socioeconomic Supports

Intervention Type BEHAVIORAL

This intervention includes the culturally tailored DPP curriculum, class procedures, and handouts along with promotional items for class participation, opportunities to attend class in-person or virtually through a digital platform, and assistance from a community health worker to provide linkage to health care services and community resources

Diabetes Prevention Program

Intervention Type BEHAVIORAL

This is the CDC TD2 evidence-based Diabetes Prevention Program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Culturally Tailored Diabetes Prevention Program

This intervention includes a culturally tailored DPP curriculum, class procedures, and handouts

Intervention Type BEHAVIORAL

Culturally Tailored DPP Enhanced with Socioeconomic Supports

This intervention includes the culturally tailored DPP curriculum, class procedures, and handouts along with promotional items for class participation, opportunities to attend class in-person or virtually through a digital platform, and assistance from a community health worker to provide linkage to health care services and community resources

Intervention Type BEHAVIORAL

Diabetes Prevention Program

This is the CDC TD2 evidence-based Diabetes Prevention Program

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Culturally Tailored DPP FIT4ALL DPP

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Black/African American
* Overweight (\[BMI\> 24); and
* Diagnosed with prediabetes OR pre-diagnosed with gestational diabetes OR high risk result on prediabetes risk test

Exclusion Criteria

* Diagnosed with diabetes
* Pregnant
* Not fluent in English
* Currently pregnant, planning a pregnancy in the next year, currently breastfeeding or have given birth in the last 6 months
* Currently participating in a weight loss program
* Currently have a medical condition that causes drastic weight loss
* Bariatric weight loss surgery in last year
* Cannot walk a 1-block distance without assistance and without stopping due to pain, tightness, or pressure in the chest
* Had heart failure
* Not willing to use a fitness tracker, wi-fi scale, and the internet
* Not available in the evening one day each week to participate in a class
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Massachusetts, Amherst

OTHER

Sponsor Role collaborator

University of Kansas

OTHER

Sponsor Role collaborator

Children's Mercy Hospital Kansas City

OTHER

Sponsor Role collaborator

University Health

UNKNOWN

Sponsor Role collaborator

University of Missouri, Kansas City

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jannette Berkley-Patton

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jannette Y Berkley-Patton, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Missouri-Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Health

Kansas City, Missouri, United States

Site Status NOT_YET_RECRUITING

University of Missouri-Kansas City

Kansas City, Missouri, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christopher Winders

Role: CONTACT

18162355370

Carole Bowe Thompson

Role: CONTACT

8162356062

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Betty Drees, M.D.

Role: primary

816-404-4070

Jannette Berkley-Patton, PhD

Role: primary

816-235-6362

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2048442

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diabetes Prevention for Black Men
NCT03708380 TERMINATED NA
Healthy Living for You
NCT05917093 COMPLETED NA
Eat Well Live Well Nutrition Program
NCT00561158 COMPLETED PHASE2